Table 1 Clinical characteristics of reports with omalizumab from the FAERS database.
Characteristics | Case number, n | Case Proportion, % |
|---|---|---|
Number of events | ||
Gender | ||
Female | 32,485 | 65.7 |
Male | 12,118 | 24.5 |
Missing | 4853 | 9.8 |
Age | ||
< 18 | 2048 | 4.1 |
18–64.9 | 16,516 | 33.4 |
65–85 | 4143 | 8.4 |
> 85 | 197 | 0.4 |
Missing | 26,552 | 53.7 |
Weight | ||
< 50 kg | 756 | 1.5 |
50–100 kg | 6440 | 13.0 |
> 100 kg | 1707 | 3.5 |
Missing | 40,553 | 82.0 |
Outcomes | ||
Death (DE) | 1954 | 4.0 |
Hospitalization(HO) | 8249 | 16.7 |
Disability (DS) | 380 | 0.8 |
Life-Threatening (LT) | 1189 | 2.4 |
Other Serious | 14,890 | 30.11 |
Missing | 22,794 | 46.1 |
Reported Person(Top five) | ||
Health professional | 3485 | 7.0 |
Consumer | 21,244 | 43 |
Physician | 17,631 | 35.6 |
Other health-professional | 5188 | 10.5 |
Pharmacist | 1500 | 3.0 |
Reported countries(Top five) | ||
America | 33,177 | 67.08 |
Canada | 5534 | 11.2 |
Switzerland | 1605 | 3.2 |
Japan | 978 | 2.0 |
Brazil | 726 | 1.5 |
Indications (Top five) | ||
Asthma | 22,836 | 46.2 |
Chronic spontaneous urticaria | 4886 | 9.9 |
Idiopathic urticaria | 4583 | 9.3 |
Product used for unknown | 10,331 | 20.9 |
Urticaria | 2788 | 5.6 |
